76 related articles for article (PubMed ID: 6558885)
1. [Malignant tumors: cancer of the cervix. Risk factors and detection].
Solal P; Soler A
Soins Gynecol Obstet Pueric Pediatr; 1983 Oct; (29):11-4. PubMed ID: 6558885
[No Abstract] [Full Text] [Related]
2. [Detection of cervix cancer in Lebanon. Reflections on 2,198 vaginal smears].
Maroun-Gédéon E
Rev Med Moyen Orient; 1967; 24(6):519-23. PubMed ID: 5264188
[No Abstract] [Full Text] [Related]
3. Smears from the cervix. Cancer cell detection.
Wells AH; Kundel DW; Helwig KL; Michaelis DL; Goldschmidt VG
Minn Med; 1968 Jan; 51(1):25-9. PubMed ID: 5636225
[No Abstract] [Full Text] [Related]
4. [Cervix cancer screening can be cost-effective. Combination of vaginal smears and the HPV test should be even more beneficial].
Bistoletti P; Ellström A; Dillner J; Sennfält K; Sparén P; Strander B
Lakartidningen; 2005 Jun 13-26; 102(24-25):1874-6, 1878-9. PubMed ID: 16044766
[No Abstract] [Full Text] [Related]
5. [Detection of cervix cancer in a department store].
Audet-Lapointe P
Union Med Can; 1969 Aug; 98(8):1361-2. PubMed ID: 5397002
[No Abstract] [Full Text] [Related]
6. Cervical and vaginal cytologic smears suggestive of adenocarcinoma.
Pretorius R; Binstock M; Sadeghi M; Hodges W
J Reprod Med; 1996 Jul; 41(7):478-82. PubMed ID: 8829059
[TBL] [Abstract][Full Text] [Related]
7. Management of abnormal cervical smears.
Br Med J; 1980 May; 280(6226):1239-40. PubMed ID: 7388485
[No Abstract] [Full Text] [Related]
8. Cervicography in evaluation of early detection of the cervical lesions.
Buković D; Fures R; Speranda Z; Silovski H; Hirs I; Mikacić I; Stancerić T
Coll Antropol; 2002 Dec; 26 Suppl():143-7. PubMed ID: 12674846
[TBL] [Abstract][Full Text] [Related]
9. Risk of invasive cervical cancer after Pap smears: the protective effect of multiple negatives.
Coldman A; Phillips N; Kan L; Matisic J; Benedet L; Towers L
J Med Screen; 2005; 12(1):7-11. PubMed ID: 15814014
[TBL] [Abstract][Full Text] [Related]
10. Cancer detection by cervical scrapings and irrigation smears. A comparative study comprising 1225 patients.
Brandt-Nielsen E; Wolthers H
Acta Obstet Gynecol Scand; 1967; 46():Suppl 9:85-92. PubMed ID: 6075718
[No Abstract] [Full Text] [Related]
11. Cervical cancer detection.
Heller EE
Minn Med; 1968 Dec; 51(12):1712. PubMed ID: 5723140
[No Abstract] [Full Text] [Related]
12. Screening for cervical cancer: recommendations and rationale.
U.S. Preventive Services Task Force
Am J Nurs; 2003 Nov; 103(11):101-2, 105-6, 108-9. PubMed ID: 14625432
[No Abstract] [Full Text] [Related]
13. [Risk factors and detection of cancer of the cervix uteri].
Solal P; Soler A
Soins Gynecol Obstet Pueric Pediatr; 1983 Oct; (29):29-30. PubMed ID: 6558888
[No Abstract] [Full Text] [Related]
14. Cancer of the cervix--problems and challenge of the 3rd millennium.
Chowdhury NN
J Indian Med Assoc; 2000 Feb; 98(2):39-40. PubMed ID: 11016147
[No Abstract] [Full Text] [Related]
15. [Diagnostic and treatment problems and prospects in precancerous and early stages of cervical cancer].
Karag'ozov A
Akush Ginekol (Sofiia); 1981; 20(4):331-7. PubMed ID: 7030097
[No Abstract] [Full Text] [Related]
16. Microinvasive cervical cancer after five negative Papanicolaou smears.
Erozan Y; Rosenshein NB; Parmley TH; Woodruff JD
Obstet Gynecol; 1983 Sep; 62(3 Suppl):82s. PubMed ID: 6877718
[TBL] [Abstract][Full Text] [Related]
17. [The effect of various factors on participation in cytologic screening in the prevention and early detection of cervical cancer].
Kavungu P; Ebeling K; Ebert S
Z Arztl Fortbild (Jena); 1983; 77(21):883-5. PubMed ID: 6659584
[No Abstract] [Full Text] [Related]
18. [New investigation method in the early diagnosis of cancers of the cervix uteri].
Giacobbe E; Giannetti G
Minerva Ginecol; 1970 Apr; 22(8):450-3. PubMed ID: 5486906
[No Abstract] [Full Text] [Related]
19. [Immunoblastic highly malignant lymphoma of the uterine cervix].
Bollermann C; Reuter T; Weber FW; Schwenzer T
Zentralbl Gynakol; 1996; 118(12):673-5. PubMed ID: 9082705
[TBL] [Abstract][Full Text] [Related]
20. Laboratory performance measures: evidence against low-risk women explaining low detection rates of high-grade abnormalities. Updated cancer information.
Mitchell HS
Cytopathology; 2006 Aug; 17(4):210. PubMed ID: 16879270
[No Abstract] [Full Text] [Related]
[Next] [New Search]
